Heartbeam, Inc. (BEAT)
Last updated: 2026-11-06 13:17:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Heartbeam, Inc. (BEAT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.41, with a market capitalization of $23.90M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.36 to $4.00. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$23.90M | |
$0.38 | |
$80.92 | |
$0.36 | |
$0.39 | |
16.89K | |
7.60M | |
-- | |
$4.00 | |
$0.36 | |
-- | |
-- |
Heartbeam, Inc. (BEAT) Pre-Market Stock Price
Heartbeam, Inc. (BEAT) is trading at $0.41 in pre-market trading as of 2026-11-06 13:14:00, up 2.86% ($0.01) from the previous close of $0.39
Pre-market trading shows how investors are pricing BEAT before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Heartbeam, Inc. (BEAT) 7-Day Stock Price Change
Over the past seven days, Heartbeam, Inc. (BEAT) moved from $0.53 to $0.41, representing a decline of 23.66% ($0.13).
The stock traded between $0.38 and $0.57 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.33 million shares, up versus the previous seven-day period, indicating higher trading activity.
BEAT 52-Week Price Position
Position in Range: 1.4%
BEAT is currently trading at $0.41, placing it 1.4% of the way from its 52-week low of $0.36 to its 52-week high of $4.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Heartbeam, Inc. (BEAT)?
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Heartbeam, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 16 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Heartbeam, Inc. (BEAT) Stock on MEXC
Eligible investors can buy real shares of Heartbeam, Inc. (BEAT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Heartbeam, Inc. (BEAT) stock price today?
2.Is BEAT stock going up or down today?
3.What is BEAT pre-market price?
4.What is BEAT after-hours price?
5.Is BEAT stock trading now?
6.Where does BEAT sit relative to its 52-week high and low?
7.What sector is Heartbeam, Inc. in?
8.What is Heartbeam, Inc.'s market capitalization and where is it listed?
9.How is BEAT valued in terms of P/E ratio and EPS?
10.Does Heartbeam, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BEAT Stock Calculator
Estimate the value between BEAT shares and USD.
BEAT Shares to USD
1.00 BEAT shares = 0.406 USD
Calculations are estimates based on the latest available price and are for reference only.


